Clinical Trial Update: Real-world Study of Acalabrutinib

View source ↗

Summary

A real-world study of acalabrutinib sponsored by Ruijin Hospital is enrolling by invitation, investigating its use in mantle cell lymphoma and chronic lymphocyt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Mantle Cell Lymphoma

Drugs mentioned

• Acalabrutinib (acalabrutinib)

Snippet

Sponsor: Ruijin Hospital | Conditions: MCL, CLL | Status: ENROLLING_BY_INVITATION